ModeX Therapeutics News and Activities

ModeX Therapeutics is owned by Opko Health.

Opko Health is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Opko Health is a company listed under the stock ticker OPK (US).

Opko Health has a direct presence in 2 countries.

Opko Health has 4 subsidiaries including Bio-Reference Laboratories, Eirgen Pharma and ModeX Therapeutics.

They are in:

• Pharmaceuticals40%
• Healthcare40%
• Other20%

View the org chart displaying its 12 main executives

Most searched biographies at ModeX Therapeutics

• Gary Nabel, President and Chief Executive Officer
• Giovanni Abbadessa, Chief Medical Officer
• Kerry Culm, Chief Development Officer

Create your alert
to follow the executive moves at ModeX Therapeutics.

Opko Health has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by ModeX Therapeutics

Social media about ModeX Therapeutics

• ModeX Therapeutics on Wikipedia, Google News & Yahoo Finance
• ModeX Therapeutics on LinkedIn, X (Twitter) & YouTube